Skip to main content
Equibles
AMN logo

AMN · Amn Healthcare Services Inc · Metrics

Track AMN — free

Use AMN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$38.02 +0.60 (+1.60%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.47B
Shares
38.56M
Volume · Nov 13 575.64K Avg daily vol (3M) 744.93K

AMN metrics

108 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$38.02
Market cap
$1.47B

Price action

23 metrics
Price change (1W)
+5.1%
Price change (30D)
-5.0%
Price change (3M)
+10.2%
Price change (6M)
+32.9%
Price change (YTD)
+141.2%
Price change (1Y)
+136.6%
Trailing year
Price change (5Y)
-65.5%
52-week high
$49.00
52-week low
$15.10
Change from 52-week high
-22.4%
Change from 52-week low
+151.8%
Annualized volatility
69.6%
Annualized volatility (3M)
59.5%
Implied volatility (30D)
46.0%
IV rank (1Y)
0.0
IV percentile (1Y)
0.0
Beta
0.6
RSI (14D)
41.7
Price vs SMA 50
-1.5%
Price vs SMA 200
+28.8%
Avg volume (3M)
744,928
Relative volume
0.8
Average dollar volume
$28.74M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
38.56M

Valuation

12 metrics
P / E (TTM)
13.8
Trailing earnings · reciprocal yield 7.3%
PEG ratio
1.5
EV / revenue
0.6×
reciprocal yield 180.0%
EV / EBITDA
5.7×
reciprocal yield 17.5%
EV / EBIT
9.6×
reciprocal yield 10.4%
P / sales
0.4×
reciprocal yield 239.9%
P / book
1.9
reciprocal yield 52.9%
FCF yield
22.3%
TTM · current market cap
Buyback yield
0.7%
P / FCF
4.5
reciprocal yield 22.3%
P / operating cash flow
4.1
reciprocal yield 24.6%
Earnings yield
7.4%

Historical valuation

8 metrics
P / E historical average (3Y)
15.0×
reciprocal yield 6.7%
P / E historical average (5Y)
13.4×
reciprocal yield 7.5%
EV / revenue historical average (3Y)
0.7×
reciprocal yield 137.6%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 119.5%
EV / EBIT historical average (3Y)
15.7×
reciprocal yield 6.4%
EV / EBIT historical average (5Y)
12.4×
reciprocal yield 8.1%
EV / EBITDA historical average (3Y)
13.8×
reciprocal yield 7.3%
EV / EBITDA historical average (5Y)
11.2×
reciprocal yield 9.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
28.4%
Operating margin
5.8%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
$998.97M
Operating profit (TTM)
$202.71M
Net income (TTM)
$109.02M
Trailing 12 months
Diluted EPS (TTM)
$2.76
FCF margin
9.3%
Effective tax rate
35.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$89.39
Gross profit per diluted share (TTM)
$25.36
Operating profit per diluted share (TTM)
$5.14
EBITDA per diluted share (TTM)
$8.67
Net income per diluted share (TTM)
$2.75
Operating cash flow per diluted share (TTM)
$9.37
Free cash flow per diluted share (TTM)
$8.52
Capital expenditures per diluted share (TTM)
$0.85
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.86
Book value per share
$16.70

Growth

11 metrics
Revenue growth YoY
+13.0%
Year over year
Net income growth YoY
+14.0%
Revenue (TTM)
$3.52B
Trailing 12 months
EPS growth YoY
+9.2%
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
-19.5%
Revenue CAGR (5Y)
+2.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-26.0%
FCF CAGR (5Y)
+1.3%

Quality

14 metrics
Return on equity
14.1%
Return on assets
4.8%
Debt / equity
1.0
Current ratio
1.2
EBITDA (TTM)
$341.52M
Free cash flow (TTM)
$327.03M
Quick ratio
1.2
Interest coverage
6.1
Net debt / EBITDA
1.4
Return on invested capital
10.3%
Trailing 12 months
Net cash
−$487.39M
Latest balance sheet
Cash & equivalents
$255.98M
Total assets
$2.29B
Total debt
$743.37M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$360.57M
Capital expenditures (TTM)
$33.53M
R&D (TTM)
—
SG&A (TTM)
$667.20M
Stock compensation (TTM)
$34.02M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
287
13F filer change QoQ
+37
Institutional ownership
121.5%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.2%
Holder tenure
14.7
Price vs estimated holder cost
+34.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.2%

Short interest

3 metrics
Short interest
11.1%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1142750 CUSIP 001744101 13F (30d) 252 filings 226 filers Visit website Investor relations